Nervgen Pharma NGEN
NASDAQ NGEN
$1.52 -0.02 (-1.30%)
As of: Oct 21, 2026 · 2:44 PM EDT

Nervgen Pharma (NGEN) Current Assets (2024 - 2026)

Updated

Nervgen Pharma's Current Assets was $64.93 million in the quarter ended Jun 30, 2026, up 337.1% from the prior quarter.

Analysis

Nervgen Pharma (NGEN) Current Assets (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, Current Assets at Nervgen Pharma came in at $16.32 million, up 17.5% from the prior year.

  • In earlier years, Current Assets was $13.89 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,136.92 Bn 1,105.50 Bn 19.71 Bn 64.67 Bn
2 Johnson & Johnson 617.57 Bn 536.10 Bn 17.26 Bn 59.77 Bn
3 AbbVie 501.37 Bn 474.48 Bn 12.70 Bn 33.67 Bn
4 Merck 367.96 Bn 322.33 Bn 12.21 Bn 36.68 Bn
5 Novartis Ag 297.98 Bn 261.97 Bn 11.24 Bn 27.35 Bn
6 Astrazeneca 261.45 Bn 235.14 Bn 12.86 Bn 27.97 Bn
7 Amgen 236.30 Bn 191.70 Bn 7.24 Bn 34.96 Bn
8 Gilead Sciences 190.27 Bn 164.46 Bn 6.22 Bn 13.95 Bn
9 Pfizer 169.65 Bn 116.29 Bn 10.94 Bn 41.36 Bn
10 Nervgen Pharma 109.94 Mn 8.82 Mn - 63.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 63.21 Mn
Mar 31, 2026 14.63 Mn
Dec 31, 2025 16.65 Mn
Dec 31, 2024 13.25 Mn
API Access

Nervgen Pharma Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=NGEN&period=max&api_key=YOUR_API_KEY